STOCK TITAN

Goodness Growth Holdings Reschedules Release of Fourth Quarter and Full Year 2022 Results to March 31, 2023

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Goodness Growth Holdings (GDNSF) announced a rescheduling of its financial results release for Q4 and full year 2022 to March 31, 2023, post-market close. The company will conduct a conference call on April 3, 2023, at 8:30 a.m. ET to discuss these results, with dial-in options provided for interested parties. Goodness Growth is focused on enhancing customer-centric operations across its cannabis business, which includes cultivation, manufacturing, and retail. Operating in five markets with 18 dispensaries, the company is dedicated to delivering quality products and supporting local communities through various programs.

Positive
  • Rescheduled financial results release may indicate improved readiness for transparency.
  • Continued commitment to customer-centric transformation could boost market position.
  • Active participation in community programs enhances corporate social responsibility.
Negative
  • None.

MINNEAPOLIS, March 29, 2023 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that it has rescheduled the release of its financial results for its fourth quarter and full year ended December 31, 2022 to Friday, March 31, 2023 after the market closes.

Goodness Growth management will host a conference call with the investment community the following business day, Monday, April 3, 2023 at 8:30 a.m. ET (7:30 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-888-414-4585 (Toll-Free) (US and Canada) or 1-646-960-0331 (Toll) (International) and referencing conference ID number 8663261.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link: https://events.q4inc.com/attendee/585633808.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc. is a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. Today, the Company is licensed to grow, process, and/or distribute cannabis in five markets and operates 18 dispensaries in four states. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.

Contact Information 
  
Investor Inquiries:Media Inquiries:
Sam GibbonsAmanda Hutcheson
Chief of Staff, VP Investor RelationsSenior Manager, Communications
samgibbons@goodnessgrowth.comamandahutcheson@goodnessgrowth.com
(612) 314-8995(919) 815-1476

FAQ

When will Goodness Growth Holdings release its financial results for Q4 2022?

Goodness Growth Holdings will release its financial results on March 31, 2023, after the market closes.

What time is the conference call for Goodness Growth Holdings on its financial results?

The conference call is scheduled for April 3, 2023, at 8:30 a.m. ET.

How can I attend the Goodness Growth Holdings conference call?

You can attend the conference call by dialing 1-888-414-4585 (toll-free US/Canada) or 1-646-960-0331 (international) and using conference ID number 8663261.

What is Goodness Growth Holdings' business focus?

Goodness Growth Holdings focuses on providing safe access to quality cannabis products and actively supporting local communities.

In how many markets does Goodness Growth Holdings operate?

Goodness Growth Holdings operates in five markets and runs 18 dispensaries across four states.

GOODNESS GROWTH HLDGS INC

OTC:GDNSF

GDNSF Rankings

GDNSF Latest News

GDNSF Stock Data

61.05M
Pharmaceutical Preparation Manufacturing
Manufacturing
United States of America
Vancouver